Eosinophil Half-life in the Lungs of Asthma patients

Eosinophil Half-life in the Lungs of Asthma patients - EHLA-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41515

Enrollment

Registered

2014-02-14

Start date

2014-06-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age > 18 and younger than 75 years • Diagnosis of eosinophil asthma • Suitable for sputum induction • >1% sputum eosinophils

Exclusion criteria

Exclusion criteria: Any infection (eg. HIV, Hepatitis, STDs) Diabetes Smoking at present or in the last 12 months and/or a past history of more than 10 pack years Antibiotic treatment for a respiratory tract infection 36 glasses per week, for females >24 glasses per week) Drug use History of cancer

Design outcomes

Primary

Measure	Time frame
Determination of eosinophil lifespans in blood and tissue in EA patients.	—

Secondary

Measure	Time frame
Lifespans of other leukocytes in blood and lungs of allergic asthma patients	—

Countries

Netherlands

Outcome results